AU8905791A - Medicaments containing sulphonamides, novel sulphonamides and proces for producing them - Google Patents

Medicaments containing sulphonamides, novel sulphonamides and proces for producing them

Info

Publication number
AU8905791A
AU8905791A AU89057/91A AU8905791A AU8905791A AU 8905791 A AU8905791 A AU 8905791A AU 89057/91 A AU89057/91 A AU 89057/91A AU 8905791 A AU8905791 A AU 8905791A AU 8905791 A AU8905791 A AU 8905791A
Authority
AU
Australia
Prior art keywords
sulphonamides
chained
producing
atoms
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU89057/91A
Other versions
AU659421B2 (en
Inventor
Hans Alois Dresel
Reinhard Heck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU8905791A publication Critical patent/AU8905791A/en
Application granted granted Critical
Publication of AU659421B2 publication Critical patent/AU659421B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Anti-atherosclerotically effective medicaments containing a compound of formula (I) in which: R1? and R2?, which may be the same or different, are a hydrogen atom or a straight-chained or branched alkyl radical with 1 to 4 C atoms; A is a straight-chained or branched alkylene chain with 1 to 5 C atoms; X is a hydrogen atom or a C1?-C4?-alkyl radical, and Y is a straight-chained or branched alkyl radical with 1 to 5 C atoms, an aralkyl or aryl radical, whereby the aryl radical may be substituted singly to triply in all possible positions on the ring by halogen, trifluoromethyl, C1?-C4?-alkyl, amino, C1?-C4?-acylamino, di(C1?-C4?)-alkylamino or nitro; with the proviso that A may also signify valency if no Y signifies an aryl radical, and their pharmacologically acceptable salts, novel sulphonamides and process for producing them.
AU89057/91A 1990-11-22 1991-11-19 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them Ceased AU659421B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4037174 1990-11-22
DE4037174A DE4037174A1 (en) 1990-11-22 1990-11-22 NEW SULPHONAMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
PCT/EP1991/002186 WO1992009571A1 (en) 1990-11-22 1991-11-19 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them

Publications (2)

Publication Number Publication Date
AU8905791A true AU8905791A (en) 1992-06-25
AU659421B2 AU659421B2 (en) 1995-05-18

Family

ID=6418735

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89057/91A Ceased AU659421B2 (en) 1990-11-22 1991-11-19 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them

Country Status (16)

Country Link
EP (1) EP0558569B1 (en)
JP (1) JPH06502632A (en)
AT (1) ATE117674T1 (en)
AU (1) AU659421B2 (en)
CA (1) CA2096847A1 (en)
DE (2) DE4037174A1 (en)
FI (1) FI932323A0 (en)
HU (1) HUT68277A (en)
IE (1) IE914044A1 (en)
IL (1) IL100120A0 (en)
MX (1) MX9102127A (en)
NZ (1) NZ240630A (en)
PT (1) PT99572A (en)
TW (1) TW264466B (en)
WO (1) WO1992009571A1 (en)
ZA (1) ZA919206B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491170A (en) * 1994-12-19 1996-02-13 Warner-Lambert Company β-carboxy sulfonamide ACAT inhibitors
CN105358531B (en) * 2013-03-14 2017-11-14 利兰-斯坦福大学初级学院的董事会 Mitochondrial aldehyde dehydrogenase-2 modulators and its application method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737316A (en) * 1971-08-31 1973-06-05 Eastman Kodak Co Two-equivalent sulfonamido couplers
US3801321A (en) * 1972-07-18 1974-04-02 Eastman Kodak Co Photothermographic element,composition and process
US4013621A (en) * 1975-04-29 1977-03-22 Ciba-Geigy Corporation Substituted sulfonamide derivatives of hindered phenols and stabilized compositions
DE2809377A1 (en) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh PHENOXYALKYL CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
IL83230A (en) * 1986-08-06 1992-06-21 Tanabe Seiyaku Co Phenoxyacetic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0325245B1 (en) * 1988-01-19 1993-10-20 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use

Also Published As

Publication number Publication date
FI932323A (en) 1993-05-21
EP0558569B1 (en) 1995-01-25
CA2096847A1 (en) 1992-05-23
IL100120A0 (en) 1992-08-18
AU659421B2 (en) 1995-05-18
IE914044A1 (en) 1992-06-03
WO1992009571A1 (en) 1992-06-11
TW264466B (en) 1995-12-01
HUT68277A (en) 1995-06-28
DE59104443D1 (en) 1995-03-09
FI932323A0 (en) 1993-05-21
MX9102127A (en) 1992-07-08
PT99572A (en) 1992-10-30
DE4037174A1 (en) 1992-05-27
EP0558569A1 (en) 1993-09-08
ATE117674T1 (en) 1995-02-15
NZ240630A (en) 1994-12-22
JPH06502632A (en) 1994-03-24
ZA919206B (en) 1992-08-26
HU9301498D0 (en) 1993-09-28

Similar Documents

Publication Publication Date Title
ES536668A0 (en) PROCEDURE FOR THE MANUFACTURE OF A RELIEF IMAGE OR A PHOTORRESISTANCE.
AU7998291A (en) Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
CA2038848A1 (en) Hydantoin derivatives
YU46998B (en) PROCEDURE FOR OBTAINING DERIVATIVES OF CEFEM AND INTERMEDIATE PRODUCTS FOR THE SAME
IE821434L (en) Arylsulphonamides.
ES8602739A1 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer.
ES8604604A1 (en) 3, 3", 4" -Tri-O-acylspiramycin I.
MX9603616A (en) Cyclopentadienyl derivatives and processes for the preparation thereof.
AU8905791A (en) Medicaments containing sulphonamides, novel sulphonamides and proces for producing them
ES8504761A1 (en) Methylflavone derivatives.
FI915245A (en) 7-ACYL-3- (SUBSTITUERADKARBAMOYLOXI) CEFEMFOERENINGAR SAMT FOERFARANDE FOER FRAMSTAELLNING AV DESSA.
ES8303316A1 (en) Disulfide type cysteine derivatives
CA2084799A1 (en) Method of prevention of prostatic carcinoma with 17 beta-n-monosubstituted-carbamoyl-4-aza-5 alpha-androst-1 -en-3-ones
GB1454864A (en) Thioureas
CA2093510A1 (en) Oxysulfonyl carbamates
GB1518042A (en) Oxadiazolinone derivatives
ES480873A1 (en) 1,2,4-Triazolidin-3-ones (and -thiones)
WO1987007609A1 (en) 1,1,2-triaryl-1-butene derivatives
ES475596A1 (en) Phenoxyalkanolamine derivatives
GB1463582A (en) Pyridine derivatives
AU2041692A (en) Antihypertensive combination
FR2448544B1 (en)
JPS5436287A (en) Thiadiazolylthiooxacephalosporin
DE58904165D1 (en) CYTOSTATICALLY EFFECTIVE TITANOCEN DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM.
JPS5239674A (en) Imidazole derivatives and agricultural bactericides therefrom